Clinical Trial Update: Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating bevacizumab and cetuximab in combination with FOLFOX6 for metastatic colorectal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• FOLFOX6

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Colon Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-07